OpenURL Connection Search

Select item for more details and to access through your institution.

Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
Published in:
British Journal of Haematology, 2024, v. 204, n. 4, p. 1232, doi. 10.1111/bjh.19325
By:
- Johnson, Isla M.;
- Karrar, Omer;
- Rana, Masooma;
- Iftikhar, Moazah;
- Chen, Sunny;
- McCullough, Kristen;
- Saliba, Antoine N.;
- Al‐Kali, Aref;
- Alkhateeb, Hassan;
- Begna, Kebede;
- Litzow, Mark;
- Hogan, William J.;
- Shah, Mithun;
- Patnaik, Mrinal M.;
- Pardanani, Animesh;
- Hermann, Joerg;
- Tefferi, Ayalew;
- Gangat, Naseema
Publication type:
Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
Published in:
American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
By:
- Karrar, Omer;
- Abdelmagid, Maymona;
- Rana, Masooma;
- Iftikhar, Moazah;
- McCullough, Kristen;
- Al‐Kali, Aref;
- Alkhateeb, Hassan B.;
- Begna, Kebede H.;
- Elliott, Michelle A.;
- Mangaonkar, Abhishek;
- Saliba, Antoine;
- Hefazi Torghabeh, Mehrdad;
- Litzow, Mark R.;
- Hogan, William;
- Shah, Mithun;
- Patnaik, Mrinal M.;
- Pardanani, Animesh;
- Badar, Talha;
- Murthy, Hemant;
- Foran, James
Publication type:
Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
Published in:
American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
By:
- Gangat, Naseema;
- Karrar, Omer;
- Iftikhar, Moazah;
- McCullough, Kristen;
- Johnson, Isla M.;
- Abdelmagid, Maymona;
- Abdallah, Mostafa;
- Al‐Kali, Aref;
- Alkhateeb, Hassan B.;
- Begna, Kebede H.;
- Mangaonkar, Abhishek;
- Saliba, Antoine N.;
- Hefazi Torghabeh, Mehrdad;
- Litzow, Mark R.;
- Hogan, William;
- Shah, Mithun;
- Patnaik, Mrinal M.;
- Pardanani, Animesh;
- Badar, Talha;
- Murthy, Hemant
Publication type:
Article

Found: 3

Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.

Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.